Literature DB >> 31605100

Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Dimitrios C Mastellos1, Anna M Blom2, E Sander Connolly3, Mohamed R Daha4, Brian V Geisbrecht5, Berhane Ghebrehiwet6, Piet Gros7, George Hajishengallis8, V Michael Holers9, Markus Huber-Lang10, Taroh Kinoshita11, Tom E Mollnes12,13,14, Robert A Montgomery15, B Paul Morgan16, Bo Nilsson17, Ruben Pio18, Daniel Ricklin19, Antonio M Risitano20, Ronald P Taylor21, Alberto Mantovani22, John P A Ioannidis23, John D Lambris24.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Year:  2019        PMID: 31605100     DOI: 10.1038/s41590-019-0531-x

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  1 in total

1.  What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review.

Authors:  Kunmeng Liu; Xiaoming Zhang; Yuanjia Hu; Weijie Chen; Xiangjun Kong; Peifen Yao; Jinyu Cong; Huali Zuo; Jian Wang; Xiang Li; Benzheng Wei
Journal:  Front Med (Lausanne)       Date:  2022-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.